Back to search

Article

A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera.

2007-05-01

Abstract excerpt

Cancer sera contain antibodies that react with autologous cellular antigens. Here, we report the use of a novel native antigen-based platform, the "reverse capture" autoantibody microarray, for identification of autoantigens against which autoantibody expression may be used to differentiate between patients with prostate cancer and benign prostate hyperplasia (BPH). Serum samples were collected at our institution...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
49eb4c16-2904-555c-a57a-cd243ef4b2c3
DOI
10.1002/prca.200700012
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera.DOI 10.1002/prca.200700012
Select a neighboring publication to make it the new centre.